Skip to main content
BVS logo

Bioventus Inc.

BVSNASDAQHealthcareMedical Devices

$13.81Today:- (-)1Y +100.73%

As of Oct 15, 2026 close

Market cap
$978.28M
P/E (TTM)
17.96
Forward P/E
-
Dividend yield
-
52-week range
$6.47$15.89
Volume (live)
-
Avg. volume (3M)
436.75K

Bioventus Inc. (BVS) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Bioventus Inc. stock.

Analyst Consensus Rating

Investment consensus from 5 professional research analysts

Consensus Rating

Buy
Based on 5 unique analysts
Medium Confidence∞:1 Buy/Sell

Average Price Target

$17.50
+26.72% upside

Loading chart...

Strong Sell
Sell
Hold
Buy
Strong Buy

Latest BVS Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Caitlin Roberts
Canaccord Genuity
BuyMaintains
$15.00 → $19.00
Unknown Analyst
Cantor Fitzgerald
BuyReiterates
$15.00
Michael Petusky
Barrington
BuyMaintains
$14.00 → $18.00
Chase Knickerbocker
Craig-Hallum
BuyReiterates
$16.00 → $18.00
Zacks Equity Research
Zacks Equity Research
BuyInitiates Coverage
-

Source: Professional analyst ratings and price targets from the last 90 days. Data as of Aug 17, 2026. Data sources and methodology

Frequently Asked Questions

What is the analyst consensus rating for BVS?

The analyst consensus rating for BVS is Buy, based on the latest ratings from 5 analysts over the last 90 days.

What is the average price target for BVS?

The average 12-month price target for BVS is $17.50, representing an upside of 26.7% from the Oct 15, 2026 close of $13.81.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.